Breckenridge Pharmaceutical

Company profile

Breckenridge Pharmaceutical company profile

Breckenridge Pharmaceutical, Inc. is a privately-held member of the Esteve Group. They are an own label Distributor that performs pharmaceutical research and development as well as marketing and distribution in the U.S. The company was founded in 1983, and markets a broad range of generic prescription products in many therapeutic categories and dosage forms. The Breckenridge label is recognized by Retail Pharmacy Chains, Mail Order Pharmacies, Pharmacy Benefit Managers, Managed Care Facilities, and Group Purchasing Organizations as well as Wholesalers and Distributors throughout the United States. They market in excess of 70 products in a variety of dosage forms including: tablets, capsules, liquids, suspensions, ophthalmics, nasal sprays, powders and injectable products. Their pipeline includes:Inhalers, Transdermal patches, and Topical products. Breckenridge, headquartered in Berlin, CT has 30 approved Abbreviated New Drug Applications (ANDA's) approved by the Food and Drug Administration (FDA). They also have over 80 products in their pipeline; including 25 that contain Paragraph IV patent challenges.